Dynamic RNA-protein assemblies and neurological disease

动态RNA-蛋白质组装和神经系统疾病

基本信息

项目摘要

Disturbances in RNA metabolism have emerged as an important contributor to several related neurological diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and inclusion body myopathy (IBM). The familial and sporadic forms of these degenerative diseases are typically characterized pathologically by cytoplasmic inclusions composed of fibrillar deposits of RNA-binding proteins (RBPs). Moreover, mutations in RBPs or other proteins that regulate RNA metabolism frequently cause the familial forms of these diseases. Over the past 7 years my lab has been at the forefront of illuminating the molecular basis for these diseases, including identifying new diseases genes, elucidating the normal function of these and other disease-related genes, and determining the consequences of disease mutations. Based on these studies we have advanced the hypothesis that disturbance in the assembly, disassembly and function of diverse RNA-protein assemblies, including cytoplasmic RNA granules, underlies the pathogenesis of the aforementioned neurological diseases. We have developed a comprehensive research program that, over the next 8 years, will investigate the molecular bases of RNA granule assembly, elucidate in detail how RNA granule dynamics are regulated, determine the role of RNA granules in spatial and temporal control of gene expression, and most importantly elucidate the mechanism whereby defects in RNA granule dynamics contribute to neurological diseases.
RNA代谢紊乱已成为几种相关神经系统疾病的重要促成因素,包括肌萎缩侧索硬化症(ALS)、额颞叶痴呆(FTD)和包涵体肌病(IBM)。这些退行性疾病的家族性和散发性形式的典型病理特征是由RNA结合蛋白(RBP)的纤维状沉积物组成的细胞质内含物。此外,调节RNA代谢的RBP或其他蛋白质的突变经常导致这些疾病的家族形式。在过去的7年里,我的实验室一直处于阐明这些疾病的分子基础的最前沿,包括识别新的疾病基因,阐明这些和其他疾病相关基因的正常功能,并确定疾病突变的后果。基于这些研究,我们提出了一个假设,即包括细胞质RNA颗粒在内的各种RNA-蛋白质组装体的组装、拆卸和功能的紊乱是上述神经系统疾病发病机制的基础。我们已经制定了一个全面的研究计划,在未来8年内,将调查RNA颗粒组装的分子基础,详细阐明RNA颗粒动力学是如何调节的,确定RNA颗粒在基因表达的时空控制中的作用,最重要的是阐明RNA颗粒动力学缺陷导致神经系统疾病的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Paul Taylor其他文献

Joseph Paul Taylor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Paul Taylor', 18)}}的其他基金

Dynamic RNA-protein assemblies and neurological disease
动态RNA-蛋白质组装和神经系统疾病
  • 批准号:
    10300049
  • 财政年份:
    2016
  • 资助金额:
    $ 89.75万
  • 项目类别:
Dynamic RNA-protein assemblies and neurological disease
动态RNA-蛋白质组装和神经系统疾病
  • 批准号:
    10063575
  • 财政年份:
    2016
  • 资助金额:
    $ 89.75万
  • 项目类别:
Dynamic RNA-protein assemblies and neurological disease
动态RNA-蛋白质组装和神经系统疾病
  • 批准号:
    10518397
  • 财政年份:
    2016
  • 资助金额:
    $ 89.75万
  • 项目类别:
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2
ALS 临床研究
  • 批准号:
    10242883
  • 财政年份:
    2014
  • 资助金额:
    $ 89.75万
  • 项目类别:
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2
ALS 临床研究
  • 批准号:
    10473844
  • 财政年份:
    2014
  • 资助金额:
    $ 89.75万
  • 项目类别:
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2
ALS 临床研究
  • 批准号:
    10020813
  • 财政年份:
    2014
  • 资助金额:
    $ 89.75万
  • 项目类别:
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2
ALS 临床研究
  • 批准号:
    10687077
  • 财政年份:
    2014
  • 资助金额:
    $ 89.75万
  • 项目类别:
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration
HDAC6 与 UPS、自噬和神经退行性疾病之间的交叉点
  • 批准号:
    8318723
  • 财政年份:
    2008
  • 资助金额:
    $ 89.75万
  • 项目类别:
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration
HDAC6 与 UPS、自噬和神经退行性疾病之间的交叉点
  • 批准号:
    8127737
  • 财政年份:
    2008
  • 资助金额:
    $ 89.75万
  • 项目类别:
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration
HDAC6 与 UPS、自噬和神经退行性疾病之间的交叉点
  • 批准号:
    7917239
  • 财政年份:
    2008
  • 资助金额:
    $ 89.75万
  • 项目类别:

相似海外基金

Investigating patological function of a novel antibody against neutrophil cytoplasmic granules
研究针对中性粒细胞胞质颗粒的新型抗体的病理学功能
  • 批准号:
    18KK0431
  • 财政年份:
    2019
  • 资助金额:
    $ 89.75万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Chemical Composition of and Enzymes Associated With Cytoplasmic Granules
细胞质颗粒的化学成分和相关酶
  • 批准号:
    5702619
  • 财政年份:
    1957
  • 资助金额:
    $ 89.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了